ERα: A biomarker and treatment target for oropharyngeal cancer?

[1]  T. Waterboer,et al.  Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma. , 2021, Oral oncology.

[2]  Hyojin Kim,et al.  Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma , 2020, Journal of Translational Medicine.

[3]  M. Muramatsu,et al.  Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus‐positive oropharyngeal cancer , 2019, International journal of cancer.

[4]  D. Hayes,et al.  Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy. , 2019, Journal of the National Cancer Institute.

[5]  A. Mäkitie,et al.  Expression of hormone receptors in oropharyngeal squamous cell carcinoma , 2018, European Archives of Oto-Rhino-Laryngology.

[6]  M. Muramatsu,et al.  APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers , 2017, Oncogene.

[7]  Xiangli Yang,et al.  [Plasma estrogen level and estrogen receptors expression in palatine tonsils in male patients with obstructive sleep apnea hypopnea syndrome]. , 2014, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[8]  S. Wain-Hobson,et al.  Human APOBEC3A Isoforms Translocate to the Nucleus and Induce DNA Double Strand Breaks Leading to Cell Stress and Death , 2013, PloS one.

[9]  S. Franceschi,et al.  Estrogen and ERα: Culprits in cervical cancer? , 2010, Trends in Endocrinology & Metabolism.

[10]  K. Korach,et al.  Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. , 2008, Cancer research.